Countries Asked To Revise IP Laws Preventing Implementation Of Farmers’ Rights 15/11/2016 by Catherine Saez, Intellectual Property Watch 1 Comment A global consultation on farmers’ rights recently co-organised by Indonesia and Norway provided recommendations to the international plant treaty, calling for the establishment of an ad hoc working group on farmers’ rights. They also recommended that contracting parties of the treaty revise their intellectual property laws and other legislation that may create obstacles for the realisation of farmers’ rights.
US Secrecy Prevails In German Constitutional Court 15/11/2016 by Intellectual Property Watch Leave a Comment The German constitutional court has rebuffed a second complaint seeking to allow oversight bodies to see the US National Security Administration (NSA) selector list.
Access To Medicine Index Finds Progress In Pharma’s Efforts 14/11/2016 by Catherine Saez, Intellectual Property Watch 1 Comment The Access to Medicine Index 2016 was published today, analysing the top 20 research-based pharmaceutical companies. The index looks at how those companies make medicines, vaccines and diagnostics more accessible in low- and middle-income countries. The index found progress in companies’ efforts to improve access but little support for flexibilities enshrined in international trade rules.
Europe Assesses “Changed World” In Trade Politics 11/11/2016 by Monika Ermert for Intellectual Property Watch Leave a Comment European Union trade politicians in several meetings this week in Brussels reflected on the future of trade policy, also impacted by the US elections. “It is a changed world, period,” Iuliu Winkler, vice-chair of the parliamentary International Trade (INTA) Committee (European People’s Party) said at the opening of the EU Trade Policy Day, expressing the general sentiment. While many members of INTA committee underlined the need of Europe to press ahead with their trade negotiations internationally, those critical of an aggressive trade agenda were eager to have their arguments not to be mixed with what was criticised as populist fear-mongering against globalisation.
Lancet Report On Essential Medicines Takes Aim At Access, Affordability 08/11/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment A much-anticipated report on progress in global access to essential medicines released today has found that change is needed to the system of paying for research and development, including moving beyond sole reliance on patents to cover R&D costs. It calls for a global R&D policy framework, a possible patent pool for essential medicines, addresses financing issues, and claims to have developed a new cost model. Meanwhile, comments ranged from two ministers from the Netherlands said the system is broken while a leading industry executive criticised it for questioning the patent system.
Union Calls “Flash Demo” After EPO Fires Another Union Representative 07/11/2016 by Dugie Standeford for Intellectual Property Watch 2 Comments The Staff Union of the European Patent Office (SUEPO) called a 7 November “flash” demonstration in Munich after the office fired Laurent Prunier, SUEPO secretary in The Hague. The move dismayed employees encouraged after the Administrative Council (AC), made up of the office’s member states, last month pressured President Benoît Battistelli into backing off from two unpopular proposals for investigating and disciplining staff.
East African Nations Agree Declaration Promoting Regional Pharma Sector Investment 07/11/2016 by William New, Intellectual Property Watch 1 Comment Senior officials from East African nations last week agreed on a declaration on promoting investment in the region’s pharmaceutical sector, spelling out terms aimed at boosting investment in ways that are locally relevant and responsible. The declaration includes: steps to standardise and improve product quality and registration, boosting government procurement of local products, setting up research centres, adopting domestic laws on intellectual property and international trade flexibilities to IP, actions against counterfeit and substandard medical products, and increasing exports. The meeting comes as local pharmaceutical production is seen to be in decline in the region.
Indian Generic Pharma Warns Against Government Caving To US Pressure On Data Exclusivity 06/11/2016 by Catherine Saez, Intellectual Property Watch 3 Comments The Indian Drug Technical Advisory Board meeting on 7 November is expected to discuss a measure that could lead to opening the way to a 10-year data exclusivity period for originator pharmaceutical companies in India, according to the Indian Pharmaceutical Alliance. The alliance submitted a letter to the advisory board to warn against consequences on public health of data exclusivity if the Indian government “succumbs to” pressure by the United States.
EU Commission Says Plants And Animals From Conventional Processes Not Patentable 04/11/2016 by Catherine Saez, Intellectual Property Watch 4 Comments The European Commission has issued its opinion on certain articles of the EU directive on biotechnological inventions, in particular the patentability of plants or animals obtained as a result of natural occurrence such as selection and crossing. The Commission found that the intention of the EU when drafting the legislation was to exclude such products from patentability.
A Summary Of International CopyCamp 2016 04/11/2016 by Guest contributor for Intellectual Property Watch 1 Comment Summary of one of the coolest annual conferences in Europe, provided by Krzysztof Siewicz, Modern Poland Foundation